Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 141 No. 0304 (2011)

Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation

  • MA Leone
  • A Ivashynka
  • MC Tonini
  • G Bogliun
  • V Montano
  • C Ravetti
  • P Gambaro
  • F Paladin
  • E Beghi
DOI
https://doi.org/10.4414/smw.2011.13155
Cite this as:
Swiss Med Wkly. 2011;141:w13155
Published
17.01.2011

Summary

PRINCIPLES: The risk of seizures increases in patients with brain tumours (BT) and brain vascular malformations (BVM), but not all risk factors are known. We aimed to identify factors that increase the risk of a first seizure in patients with BT or BVM.

METHODS: Multicentre case-control study; 102 cases with a first seizure as a presenting symptom of BT or BVM; 121 hospital controls with BT or BVM, but without seizures, matched by centre, gender and age.

RESULTS: In the univariate analysis, the risk of first seizure (Odds Ratio, 95% Confidence Limits) was 6.4 (2.3–17.6) for supratentorial lesions, 4.7 (2.4–9.3) for cortical involvement, 2.5 (1.0–7.7) for family history of seizures, and 2.1 (1.2–4.1) for frontal location. The types of lesion with higher risk were low grade glioma (4.7; 1.7–13.9) and cavernous malformations (13.2; 2.1–58.0). After multivariate analysis, including all the imaging characteristics and family history, the strongest independent predictors of first seizure were cortical involvement (OR 4.0; 2.0–8.1) and type of lesion (low grade glioma: 4.0; 1.3–12.8; cavernous malformations: 12.6 (1.5–103.5).

CONCLUSIONS: Cortical involvement and type of lesion are the independent risk factors for a first-ever seizure as a presenting symptom of BT or BVM.

References

  1. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, ChBVMerlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886–93.
  2. Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109:634–8.
  3. Pace A, Bove L, Innocenti P, Pietrangeli A, Carapella CM, Oppido P, et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res. 1998;17:479–82.
  4. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421–30.
  5. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol. 2005;4:299–308.
  6. Hwang SL, Lin CL, Lee KS, Lieu AS, Kuo TH, Chang CZ, et al. Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir. (Wien) 2004;146:589–94.
  7. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disoders in patients with malignant gliomas. Arch Neurol. 1995;52:717–24.
  8. Shamji MF, Fric-Shamji EC, Benoit B. Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev. 2009;32:275–85.
  9. Leone M, Bottacchi E, Beghi E, Morgando E, Mutani R, Cremo R, et al. Risk factors for a first generalized tonic-clonic seizure in adult life. Neurol Sci. 2002;23:99–106.
  10. Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996;61:433–43.
  11. Leone M, Tonini C, Bogliun G, Monaco F, Mutani R, Bottacchi E, et al. Chronic alcohol use and first symptomatic epileptic seizures. J Neurol Neurosurg Psychiatry. 2002;73:495–9.
  12. Leone MA, Tonini MC, Bogliun G, Gionco M, Tassinari T, Bottacchi E, et al. Risk factors for a first epileptic seizure after stroke: A case control study. J Neurol Sci. 2009;277:138–42.
  13. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501.
  14. Commission on Epidemiology and Prognosis, International League against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–6.
  15. http://www.dceg.cancer.gov/tools/design/power
  16. SAS Institute Inc. SUGI supplemental library user’s guide. Version 8 edition. Cary, NC: SAS Institute, 1999-2001.
  17. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124:1900–26.
  18. Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology. 2002;59:S21–6.
  19. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5:659–70.
  20. Schaumann BA, Annegers JF, Johnson SB, Moore KJ, Lubozynski MF, Salinsky MC. Family history of seizures in post-traumatic and alcohol withdrawal seizure disorders. Epilepsia. 1994;35:48–52.